J. Posada

发表

Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study

P. Smolak, R. Levin, R. Martin, 2017, Lupus.

Blood-Borne RNA Correlates with Disease Activity and IFN-Stimulated Gene Expression in Systemic Lupus Erythematosus

Richard W. Martin, Stanley B. Cohen, D. Chaussabel, 2016, The Journal of Immunology.

W. Ng, J. Posada, B. Fisher, 2021 .

Applications therapeutiques de polypeptides flint

J. Posada, D. Wierda, Fredric J. Cohen, 1999 .

Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren’s Syndrome: A Randomized Clinical Trial

P. Gallagher, J. Tarn, J. Casement, 2020, Arthritis & Rheumatology (Hoboken, N.j.).

Nuclease Therapy Improves Severe Fatigue in Primary Sjögren's Syndrome: A Randomized Clinical Trial.

P. Gallagher, J. Tarn, J. Casement, 2020, Arthritis & rheumatology.